Unlocking the Mycobacterial Cell Wall: Insights into Virulence, Biosynthetic Pathways and systems-based approach to drug discovery  by Verma, P. et al.
e th In
f
(
C
2
(
P
(
t
f
B
2
ﬁ
i
i
h
g
M
f
J
p
S
f
t
s
t
c
t
c
c
2
s
a
g
M
i
o
t
b
p
i
i
n
c
L
C
i
o
r
S
C
i
d
S
6
M
R
d
m
e
i
s
h
o
t
s
b
i
t
r
p
t
n
a
i
r
e
f
d
T
t
6
U
V
a
P
1
2
I
3
t
w
d
a326 14
ollows: Argentina, 42% (n = 5851 isolates); Bolivia, 36%
n = 1167); Chile, 80% (n = 246); Colombia, 47% (n = 4214);
osta Rica, 58% (n = 674); Cuba, 6% (n = 80); Ecuador,
5% (n = 1363); Guatemala, 64% (n = 1483); Honduras, 12%
n = 393); Mexico, 52% (n = 497); Nicaragua, 20% (n = 296);
araguay, 44% (n = 980); Peru, 80% (n = 1407); Uruguay, 59%
n = 1431) and Venezuela, 25% (n = 2114).
Similarly, data submitted to the Pan-American Associa-
ion of Infectious Diseases for the year 2006 showed the
ollowing rates of HA-MRSA: Argentina 51%; Bolivia 55%;
razil 54%; Chile 29%; Ecuador 25%; Mexico 32%; Panama
8%; Paraguay 30%; Uruguay 24%; and Venezuela 27% The
rst published report of CA-MRSA infections in Latin Amer-
ca came from Brazil, where three wellcharacterized strains,
solated from patients with SSTIs or septic arthritis in 2003,
arbored SCCmec type IV, PVL, enterotoxin and #-hemolysin
enes. A further report followed of a large outbreak of CA-
RSA infection that affected inmates in jails and people
rom the community in Montevideo, Uruguay, beginning in
anuary 2002. At the end of the outbreak, more than 1000
atients had been affected and 12 deaths had occurred.
STIs accounted for more than 65% of the cases, but severe
orms of pneumonia were reported, including 4 deaths. In
his outbreak, TMP-SMX was very active in the treatment of
kin infections.
Since those ﬁrst reports, MRSA has been identiﬁed as
he cause of community-acquired infections in several more
ountries across South America. In Lima, 27% resistance
o methicillin was reported in isolates collected from 30
ommunity-acquired infections in 2002. Two cases of SSTI
aused by CA-MRSA strains were reported from Bogotá in
006, and a report from the Colombian network of resistance
urveillance showed an increase in CA-MRSA from 1% of S.
ureus isolates in 2001 to 5.4% in 2006 [21]. The PAHO pro-
ram has also included surveillance of community-acquired
RSA infections since 2005, and in Venezuela, 12.4% of 845
solates of S. aureus from the community were resistant to
xacillin. However, no clinical information is available for
hese cases. A few isolated cases of CA-MRSA infection have
een reported in Chile, but some of these were in peo-
le returning from cities in Uruguay or Brazil with a high
ncidence of MRSA.
MRSA is an increasing problem in Latin America, both
n the healthcare environment and in the community. In
osocomial S. aureus infections, the frequency of methi-
illin resistance has surpassed 50% in over half of the
atin American countries for which data were identiﬁed.
ommunity-acquired-MRSA has been reported in Latin Amer-
ca and even though large outbreaks such as the one that
ccurred in Uruguay — causing 12 deaths — have not been
eported elsewhere, this example highlights the problem.
urveillance programs are only recently beginning to record
A-MRSA, and the true incidence of MRSA in the community
s still largely unknown in the region.
oi:10.1016/j.ijid.2010.02.2213
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7.001
icrobial chemical ecology and the future of antibiotics
. Kolter
Harvard Medical School, Boston, MA, USA
When it comes to cell-to-cell communication the pre-
ominant language is that of small signaling molecules. The
icrobial world is no exception - microbes are known to
xchange messages both within and across species by secret-
ng and recognizing small molecule natural products. Among
uch compounds can be found many of the antibiotics that
ave been extensively used in medicine since the middle
f the last century. Concomitant with their use has been
he evolution of antibiotic resistance. In order to under-
tand the phenomenon of antibiotic resistance and to devise
etter strategies for future antibiotic discovery and use it
s useful to consider this topic from an ecological perspec-
ive. In this sense, it is important that to recognize that we
emain largely ignorant of the role that antibiotic substances
lay in environmental settings. Work that I will discuss in
his lecture supports the idea that antibiotics can serve
on-lethal signaling functions in bacteria - both within and
cross species. In addition, I will discuss instances in which
nterspecies interactions mediated by small molecule natu-
al products lead to narrow spectrum action of antibiotics in
cological settings. These results suggest new ways to look
or and use antibiotics in the future.
oi:10.1016/j.ijid.2010.02.2214
uberculosis: Tools for the Future (Invited Presen-
ation)
8.001
nlocking the Mycobacterial Cell Wall: Insights into
irulence, Biosynthetic Pathways and systems-based
pproach to drug discovery
. Verma1, A. Goyal2, R. Sankaranarayanan2, R. Gokhale3,∗
National Institute of Immunology, Delhi, India
Centre for Cellular and Molecular Biology, Hyderabad,
ndia
Institute of Genomics & Integrative Biology, Delhi, India
Biosynthetic machinery of complex lipids in Mycobac-
erium tuberculosis (Mtb) includes a family of FadD proteins,
hich are otherwise universally involved in fatty acid degra-
ation. Mtb produce several exotic lipids, many of which
re important for its virulence as well as survival in the
ost. By combination of structural, genetic and biochem-
cal studies, we have identiﬁed several novel mechanisms
nd pathways that generates complex cell envelope lipids.
e show that polyketide synthase in conjunction with a
ew family of fatty acyl AMP ligases (FAALs) in Mtb are
nvolved in biosynthesis of lipids. Based on the structure
f a FAAL homologue and by generating loss- as well as
ain-of-function mutants, we show that an insertion motif
ictates the synthesis of acyl-adenylates or acyl-CoA, and
hus bifurcates metabolic fate of fatty acids. Since FAALs
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Brazilian criteria for LTBI treatment strongly suggests that a
change on these criteria could have a direct impact on TB
control.14th International Congress on Infectious Diseases (ICID) Abs
are focal nodes in biosynthetic network of virulent lipids,
inhibitors directed against these proteins provide a unique
multi-pronged approach of simultaneously disrupting several
pathways in lipid metabolism. Our study illustrate how obli-
gate pathogens like Mtb have evolved such novel themes
of functional versatility to generate unusual metabolites.
We also reveal possible evolutionary path traced by FAALs
from omnipresent fatty acyl CoA ligases. Furthermore, our
study also provide credence to the ‘systems pharmacology’
approach for drug discovery.
doi:10.1016/j.ijid.2010.02.2215
68.002
Diagnosing Drug Resistance in Low-Resource Settings:
Practical Approaches
A. Umubyeyi Nyaruhirira1,∗, T. Martine2, F. Portaels3, V.
Greet4
1 Corunna, Rwanda
2 TB Program, Kigali, Rwanda
3 Tropical Institute of Medicine, Brussels, Belgium
4 ICAP, Columbia University, Rwanda, Kigali, Rwanda
Tuberculosis (TB) remains one of the major causes of
death from a single infectious agent worldwide. Of great
concern for TB control is the emergence of drug resistance.
Since there is no cure for some multidrug-resistant strains of
Mycobacterium tuberculosis, there is concern that they may
spread around the world, stressing the need for additional
control measures, such as new diagnostics, better drugs for
treatment, and a more effective vaccine. Pulmonary TB can
be diagnosed by its symptoms, chest radiography, sputum
smear microscopy and by cultivation of M. tuberculosis,
which is considered as the gold standard. Recent advances
in molecular biology and molecular epidemiology, and a bet-
ter understanding of the molecular basis of drug resistance
in TB, have provided new tools for rapid diagnosis; how-
ever, the high cost of most of these techniques, and their
requirement for sophisticated equipment and skilled person-
nel have precluded their implementation on a routine basis,
especially in low-income countries. Other nonconventional
diagnostic approaches proposed include the search for bio-
chemical markers, detection of immunological response and
early detection of M. tuberculosis by methods other than
colony counting. In the present mini review, some of these
approaches will be reviewed and the feasibility for their
implementation in diagnostic laboratories will be discussed.
However, with the resurgence of interest in the develop-
ment of new tools for TB control, and the recent inﬂux of
funding and political support, it is likely that the next few
years will see the introduction of new diagnostic tools into
routine TB control programs and particularly in high disease
burden, and resource-poor countries.
doi:10.1016/j.ijid.2010.02.2216
dts e327
8.003
pplicable Insights from Pharmacokinetic and Pharmaco-
ynamic Modeling of Antituberculosis Chemotherapy
. Nuermberger
Johns Hopkins University, Baltimore, USA
Current chemotherapy for tuberculosis leaves consid-
rable room for improvement. Major objectives include
hortening the duration of therapy necessary for cure,
mproving the efﬁcacy of intermittent treatment regimens,
nd preventing the development of drug resistance. Bet-
er understanding of the pharmacodynamic relationship
etween drug exposure and drug effect will identify strate-
ies for optimizing drug effect in order to achieve these
bjectives, thereby informing pre-clinical drug develop-
ent, clinical trial design and clinical practice. Recent work
n in vitro and animal models involving both new and exist-
ng antituberculosis drugs will be reviewed and discussed in
his context.
oi:10.1016/j.ijid.2010.02.2217
8.004
ddressing Latent TB in Areas with High TB Burden: Impli-
ations for Control
. Conde
Hospital Universitario Clementino Fraga Filho, Rio de
aneiro, Brazil
Brazil is a country in South America with a total popu-
ation of 191 million of people (81% urban; 19% rural) with
n estimated incidence of 92,000 new cases of tuberculo-
is (TB) yearly (data from 2007). Treatment of latent TB
nfection (LTBI) in Brazil is currently recommended only
n the case of contacts of pulmonary smear-positive TB
atients aged % 15 years with a tuberculin skin test (TST)
‘10mm and no previous bacilli Calmette-Guérin (BCG) vac-
ination or with a TST’’ 15mm regardless of previous BCG
accination. However, a recent retrospective cohort study
valuating contacts aged ‘‘15 years who did not meet the
razilian criteria for LTBI treatment shown a TB incidence
f 3.2% (22/667), with an estimated TB rate of 1,649 per 100
00 population. The risk of TB was greater among the 349
ontacts with TST’’ 5mm (5.4%) compared to the 318 con-
acts with TST < 5mm (0.9%; RR 6.04, 95%CI 1.7—20.6). The
igh incidence of TB among contacts who did not meet theoi:10.1016/j.ijid.2010.02.2218
